1. Does Intel have a contingent liability with relation to the potential future costs associated with the chip's flaw? If so, when should management have recognized a liability on the company's balance sheet for this contingent liability? How should the company report this contingent liability in its financial statements issued before the capitalization decision? What are the accounting entries for recognizing and derecognizing the liability